Are IPOs worth the gamble? This investment panel’s answers may surprise you
Considering an IPO? A MedCity INVEST panel of investors and entrepreneurs shared some sobering insights from their experience.
Hawkins exit may show Medtronic’s need for bold leader/big deals
When Medtronic Inc. (NYSE:MDT) CEO Art Collins retired in 2007, there were at least two top candidates vying to replace him. One was Michael DeMane, the brash president of Medtronic's spine business whose aggressive pursuit of growth invited legal and regulatory scrutiny. The other was chief operating officer Bill Hawkins, a steady, stabilizing presence within Medtronic's senior leadership team.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Michael DeMane out as CEO of Lanx Inc. Was he ever really in?
Well, that was quick. In a bizarre twist, Lanx Inc., an orthopedics startup in Colorado, said that former Medtronic chief operating officer Michael DeMane is no longer its CEO and chairman, less than a month after naming him to those positions. “Michael DeMane has declined to assume the role of chairman and chief executive officer […]
Former Medtronic chief operating officer joins spine firm in Colorado
Michael DeMane is finally a CEO. The former chief operating officer at Medtronic Inc. (NYSE: MDT), once thought to be a top candidate to lead the world’s largest medical device firm, recently joined Lanx Inc. as chairman and CEO. The company, based in Broomfield, Colo., makes devices for spinal surgeries. Investors include Chicago Growth Partners, […]